Nanologica AB (publ) (NICA.ST)
Nanologica AB (publ) operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Södertälje, AB, SE. The stock last traded at $0.31, down 0.64% on the session, giving a market capitalisation of $101.9M. Its beta of -0.07 implies it has historically moved less than the broad market.
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
Nanologica AB (publ) is most often compared with the following Healthcare names: